Solensia

The First and Only FDA-Approved Treatment to Control Osteoarthritis Pain in Cats

Down-arrow.gif

Solensia

The First and Only FDA-Approved Treatment to Control Osteoarthritis Pain in Cats

Down-arrow.gif

Treatments

Treatment options for cats with osteoarthritis are very limited. Advancements in modern veterinary medicine have been instrumental in extending the lives of many animals, including cats. But with longer lives come chronic diseases, such as osteoarthritis,” said Steven M. Solomon, M.P.H., D.V.M., director of the FDA’s Center for Veterinary Medicine. “Today’s approval marks the first treatment option to help provide relief to cats that are suffering from this condition and may significantly improve their quality of life. We also hope that today’s approval of the first monoclonal antibody by the FDA for any animal species will expand research and development of other monoclonal antibody products to treat animal diseases.